MXCT - MaxCyte and Lion TCR join hands for Lion TCR's global expansion
2024-01-03 10:22:28 ET
More on MaxCyte
- MaxCyte May Benefit From Potential Gene Therapy Approval
- MaxCyte announces departure of founder and CEO Doug Doerfler
- Gene editing stocks mixed despite world’s first CRISPR drug approval
For further details see:
MaxCyte and Lion TCR join hands for Lion TCR's global expansion